MoneyWorks4Me

Wockhardt informs about press release

03 Apr 2017 Evaluate

Wockhardt has informed about Press Release titled ‘Wockhardt receives acknowledgement of its breakthrough superdrug Antibiotic WCK 5222 for Phase III Clinical Trial from US FDA’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..